DIA has held the DIA Asia New Drug Conference over 12 years in Japan, but this time, with the introduction of the new ICH framework, we will start a new conference series called “DIA Asia International Conference”. This year, the ICH has determined to allow multiple Asian regulators to join ICH as official members, drastically changing from 3 originating regions of the US, EU and Japan.
These countries are all moving to a new era when they can introduce common pharmaceutical regulations and discuss issues on the same foundation. To meet the unmet medical needs, regulators are trying to accelerate the drug development, including the introduction of an expedited review process. Asian academies/companies also change the methods using various new technologies to find a solution. It is becoming necessary to pay an effort to understand both cutting-edge science and technology and changes in medical needs, flexibly responding to patient expectations.
Visit ERT at Booth H to discuss how our clinical trials solutions can help you move forward with confidence.